4Cengiz H, Ya§ar L, Ekin M et al. Management of intractablepostpartum haemorrhage in a tertiary center : A 5 - year experi-ence [J] .Niger Med J, 2012, 53 (2); 85.
5Chu CS, Brhlikova P, Pollock AM. Rethinking WHO guid-ance :review of evidence for misoprostol use in the preventionof postpartum haemorrhage[J]. J R Soc Med,2012,105(8); 336.
6Solomon C,Collis RE, Collins PW. Haemostatic monitoringduring postpartum haemorrhage and implications for manage-ment [J]. Br J Anaesth, 2012,109 (6): 851.
7Chu CS, Brhlikova P, Pollock AM. Rethinking WHO guid- ance: review of evidence for misoprostol use in the preven- tion of postpartum haemorrhage [ J ]. Soc Med, 2012, 105 (8) :336-347.
8Sekhavat L, Tabatabaii A, Dalili M, et al. Efficacy of tranexamic acid in reducing blood loss after cesarean section [ J ]. Journal of Maternal-Fetal and Neonatal Medicine,2009,22( 1 ) :72-75.
9Koh E, Devendra K, Tan L K. B-Lynch suture for the treatment of uterine atony[ J]. Singapore Medical Journal,2009,50(7) :693-697.
10Sekhavat L, Firuzabadi R D, Zarchi M K. Effect of postpartum oxygen inhalation on vaginal blood loss[ J]. Journal of Maternal-Fetal and Neonatal Medicine,2009,22( 11 ) :1072-1076.
